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In vivo screening of extracellular matrix components
produced under multiple experimental conditions
implanted in one animal†
Gustavo A. Higuera,z*b Jeanine A. A. Hendriks,zc Joost van Dalum,a Ling Wu,a
Roka Schotel,c Liliana Moreira-Teixeira,a Mirella van den Doel,c Jeroen C. H. Leijten,a
Jens Riesle,c Marcel Karperien,a Clemens A. van Blitterswijka and Lorenzo Moronia
Animal experiments help to progress and ensure safety of an increasing number of novel therapies,
drug development and chemicals. Unfortunately, these also lead to major ethical concerns, costs and
limited experimental capacity. We foresee a coercion of all these issues by implantation of well systems
directly into vertebrate animals. Here, we used rapid prototyping to create wells with biomaterials to
create a three-dimensional (3D) well-system that can be used in vitro and in vivo. First, the well sizes
and numbers were adjusted for 3D cell culture and in vitro screening of molecules. Then, the
functionality of the wells was evaluated in vivo under 36 conditions for tissue regeneration involving
human mesenchymal stem cells (hMSCs) and bovine primary chondrocytes (bPCs) screened in one
animal. Each biocompatible well was controlled to contain ml-size volumes of tissue, which led to tissue
penetration from the host and tissue formation under implanted conditions. We quantified both
physically and biologically the amounts of extracellular matrix (ECM) components found in each well.
Using this new concept the co-culture of hMSCs and bPCs was identified as a positive hit for cartilage
tissue repair, which was a comparable result using conventional methods. The in vivo screening of
candidate conditions opens an entirely new range of experimental possibilities, which significantly
abates experimental animal use and increases the pace of discovery of medical treatments.
Insight, innovation, integration
Well-plates and their experimental throughput, as invented by Dr Gyula Takatsy in 1951, are indispensable tools in biological research, where biological data
throughput remains solely optimised in vitro. Here, we created implantable well-plates to increase the throughput of animal experiments. By creating wells with
biocompatible materials, it was possible to evaluate ml-size volumes of tissue in vitro and in vivo and to obtain quantitative correlations of multiple conditions
vs. biological markers directly in animal models. This approach embodies a practical strategy to reduce the numbers of experimental animals that rely on
analysing tissue biology in units (wells) that can be controlled and compared with other units of real tissue.
Introduction
New biomedical treatments spend years in the preclinical phase
due to the inherent difficulties in translating1,2 in vitro results
into in vivo settings and their subsequent rounds of decisive3,4
validation in ethically and financially costly animal models.
While novel in vitromethods5 have boosted the throughput of data
and predictability of treatments in animals, the benefit of in vitro
models to forecast in vivo effects has not been definitely proven.1,6
For example, novel drug screening methods7 do not consider
physical phenomena typical of three-dimensional (3D) tissues such
as molecular diffusion and gradient profiles. In such cases, in vitro
validation for drug and treatment development depends on gene
expression profiles that usually differ from the effects of sharp
molecular gradients of the native 3D milieu.
Another approach to replacing animal experiments has seen
the rise of promising 3D8 and micro-fabricated systems9–13 that
try to mimic the cellular environment. These systems capture
some of the complexity of the 3D environment; that is, the role
of physics in tissue biology.14 However, most of these fall
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short of representing real tissue and replacing animal models.
Inevitably, millions of animals are bred every year to evaluate
the impact of substances and treatments on the environment
and human health.
A notable example for optimizing animal experiments has been
achieved in evaluating biocompatibility,15 where 8 biomaterials can
be spatio-temporally assessed in one animal through fluorescence
imaging. Even though the physiological consequences for
implanting multiple conditions (e.g. materials, drugs or toxins)
in one animal cannot be predicted, and must therefore be
investigated, there is a tangible social and economic benefit of
increasing the efficiency of experiments directly in animal models.
Here, we integrate methodology in rapid prototyping, 3D cell
culture and ECM biology to present in vivo screening as a
viable strategy for refining animal experiments. To make this
possible, we made an implantable well-system that enables
screening in vitro and directly in an animal model for tissue
regeneration. For cell culture, human mesenchymal stem cells
(hMSCs) and bovine primary chondrocytes (bPCs) were chosen as
cell sources for their extensively studied therapeutic potential. We
focus on screening of ECM components as markers of the tissue
formation potential of 36 cell conditions in one animal.
Results and discussion
To screen in vivo, that is, to implant multiple conditions
directly in one animal, conventional platforms and screening
materials such as polydimethylsiloxane (PDMS) would not be
ideal due to biocompatibility concerns. Therefore, we decided
to create a platform made of biomaterials. The versatility of free
form fabrication allowed us to manufacture16 a system of wells
with a wide range of materials (Table S1 and Fig. S1, ESI†), where
the well, numbers, material and architecture can be defined
depending on the implantation site of the animal (Fig. 1). These
implantable devices consist of mm3 to mm3 size wells organized in
column  row arrays.
We then tested the robustness of wells by dispensing specimens
that could be manually seeded and that were compatible with
standard laboratory equipment (Fig. S2, ESI†) such as an automatic
confocal microscope (Fig. S2B, ESI†). In these in vitro experiments,
the wells were randomly seeded with dyes of different
colors (Fig. S2A–E, ESI†) to confirm that there was no cross-
contamination between different wells and unbiased readouts.
We first usedmicrospheres and fluorescentmarkers (Fig. S2F, ESI†)
to evaluate if compounds with different sizes and fluorescent
properties could be quantified in the wells. The intensity of light
emitted from poly lactic acid wells containing microspheres
revealed that the mean fluorescent intensity (n = 3) significantly
decreased with increasing dilution factors (Fig. S2B, ESI†).
When the fluorescent markers rhodamine and fluorescein
isothiocyanate (FITC) were seeded at different dilutions in
photo-sensible resin-made wells (Fig. S2F, ESI†), these also
displayed a significant correlation between the dilution factor
and mean light intensity (Fig. S2G, ESI†). Overall, these results
demonstrated that wells could be implemented in vitro for the
screening and quantification of molecules. In practice, these
Fig. 1 Screening systems can be made of different sizes, materials and architectures.We were able to manufacture: 1024 wells in a 32 32 matrix made of PEOT–PBT
of 300/55/45 composition (A); 100 wells in a 10  10 matrix made of PEOT–PBT of 1000/70/30 composition (B); 100 wells in a 10  10 matrix made of poly lactic acid
(C); 100 wells in a 10  10 matrix made of alginate (in PBS) (D). The architecture of well systems could also be modified to create: a double matrix (top and bottom of a
system) with a polymer layer in between (E); wells with a porous layer of material in the middle for potential co-culture studies (F).White arrow points to the pipette tip
size that fits into a well. Scale bar: 1 mm.
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results showed that up to 9 wells per screening device could be
consistently dispensed manually, and that the sensitivity of
results was not compromised by the materials or the designs.
As a popular tissue regeneration cell source, hMSCs were
selected for testing the cell culture compatibility of wells (Fig. 2)
made of PEOT–PBT, a biocompatible copolymer already used in
skin and musculoskeletal regenerative medicine applications.8
The material was selected for its slow in vivo degradation,17 low
water uptake (B5%) and high tensile strength (up to 23 MPa).18
In addition, attachment, proliferation and differentiation of
chondrocytes16 and hMSCs19 can be tuned by varying the PEOT/
PBT ratio of the copolymer chains. A 2D film of the material itself
showed that when hMSCs were cultured on 300PEOT55PBT45
discs, cells organized in colony forming units (CFU’s) (Fig. 2A),
which resembled their known monolayer behavior on tissue
culture plastic. In contrast, hMSCs cultured on rectangular
wells formed 3D aggregates conditioned by the number of cells
seeded (Fig. 2B). Remarkably, wells with the highest number of
hMSCs contained 3D aggregates of random shapes whereas
dilutions of hMSCs yielded wells with monolayer-type cultures.
We determined that 3D aggregates augmented in size in a time-
dependent manner due to the non-monolayer aggregation of
hMSCs. To examine the effect of well-volume on hMSCs, the
well size was varied in width and length and 1.2  104 hMSCs
were seeded in three different types of wells (Fig. 2C–E), which
effectively increases the cell concentration by decreasing the well
volume instead of increasing the cell numbers. By adjusting the
well size, an inverse correlation between hMSCs organization
and well size was derived: hMSCs form 3D aggregates in the
0.45 ml well (Fig. 2C), while in the 1.8 and 4 ml wells (Fig. 2D
and E) they organized into CFU’s, leading to the conclusion that
above 5  104 cells per ml of well hMSCs readily assemble in 3D
aggregates. When low numbers of hMSCs are deposited in the
well, these proliferate, increasing the cell concentration in time
(Fig. 2F). From these data, we discovered that the 3D organiza-
tion of hMSCs in the wells could be controlled through the well
volume, cell number and culture time.
Based on molecular and cell culture results, we chose to
fabricate PEOT–PBT screening systems with 9 wells and volumes
of 1.8 ml per well. This meant that thirty six conditions could be
housed in four subcutaneous sites in every immune-deficient
mouse (Fig. S3, ESI†). The thirty six implanted conditions
consisted of numbers of hMSCs, numbers of bovine primary
chondrocytes (bPCs) and coculture ratios of hMSCs : bPCs that
were screened for tissue regeneration markers (Table 1).
First, the systemic effect on the host tissue under the
different conditions confined in the screening device was
assessed in all twenty mice with markers for the cell nuclei,
the cytoplasm of cells, keratin and collagen (Fig. 3). Interestingly,
hair growth (Fig. 3A) was stimulated on the skin of nude mice
Fig. 2 Cell culture in the PEOT–PBT wells. 300 000 cells seeded on 2D PEOT–PBT colony forming units of methylene blue stained hMSCs. (A, top view), scale bar:
0.2 mm.When hMSC dilutions were tested in the PEOT–PBTwells, 25 000 hMSCs per ml produced 3D aggregates (B, cross section), scale bar: 0.5 mm.Varying the size of
the wells and seeding 12 000 hMSCs in all well volumes showed that 0.45 ml wells induce 3D aggregate formation whereas 1.8 and 4 ml wells do not (C–E, cross section,
scale bar: 0.2 mm). hMSC concentrations increase in time due to proliferation (F). One-way ANOVA followed by Tukey’s post hoc test was used to evaluate statistical
significance, where bars and error bars represent the mean cell number (n = 9 wells) and their standard deviation, respectively (p o 0.01).
Integrative Biology Technical Innovation
D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ite
it 
Tw
en
te
 o
n 
13
/0
5/
20
13
 0
7:
07
:3
7.
 
Pu
bl
ish
ed
 o
n 
17
 A
pr
il 
20
13
 o
n 
ht
tp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C3
IB4
002
3A
View Article Online
Integr. Biol. This journal is c The Royal Society of Chemistry 2013
in wells containing hMSCs, indicating a systemic response to
trophic factors.20 Upon histopathological examination of tissue
morphology in slides from all mice, there was no indication of
cross-contamination of conditions or inflammatory responses
(Fig. 3A). Instead, the first evident effect was the penetration/
formation of tissue in the wells (Fig. 3B).
To evaluate the presence of tissue in the wells, we quantified
the physical accumulation (tissue area/total well area) of tissue
in each well for all mice (Fig. 4). Since the objective was to
compare tissue penetration in all wells vs. the total well area,
the analysed tissue area included implanted cells, host tissue
and new ECM. Then we proceeded to identify patterns in time
according to each condition. For example, the percent area of
tissue in a well increased gradually with increasing numbers of
hMSCs (Fig. 4A). Also bovine PCs exhibited an increase in tissue
percent areas with increasing cell numbers on week 4 (Fig. 4B),
but not on week 2. Despite seeding a maximum of 25 000 cells
in all wells, co-cultures revealed growing tissue percent areas
for wells containing increasing numbers of hMSCs (Fig. 4C).
We analyzed the means of the percent area of tissue to
determine whether there were significant differences between
conditions. These led to variability of results between members
of the same species when comparing all mice with each other.
In wells with hMSCs, half of the mice displayed a significantly
higher percent area of tissue between 6000 cells vs. control (no
seeded cells, week 2), and 25 000, 12 000 cells vs. control (week
4) (Table S1, ESI†). Similarly, in wells with bPCs, half of the
mice presented a significantly higher percent area of tissue
between 25 000 cells vs. 12 000 cells (weeks 2 and 4), 12 000 cells
vs. control (week 2) (Table S2, ESI†). Finally, in wells with
co-cultures, 56% of the mice revealed significantly higher percent
areas of tissue in the 20000 hMSCs to 5000 bPCs (80 : 20) ratio vs.
control (week 4) (Table S3, ESI†). Notably, there was no indication
that the implantation site influenced the correlation between cell
numbers and tissue percent areas according to the random
distribution of conditions (Fig. S2, ESI†).
Table 1 Cell numbers for human mesenchymal stem cells (hMSCs), bovine
primary chondrocytes (bPCs) and co-cultures screened with three replicates per
cell condition and 9 control (empty) wells for a total of 36 conditions in each
mouse
Dilution
factor
hMSCs
[cell #]
bPCs
[cell #]
Co-culture
ratios
hMSCs : bPCs
[cell #]
1 25 000 25 000 80 : 20 20 000 : 5000
2 12 500 12 500 50 : 50 12 500 : 12 500
4 6000 6000 20 : 80 5000 : 20 000
Fig. 3 In vivo screening is performed on histological sections showing three wells of a well system with the subcutaneous host tissue located above the wells. The
representative staining of 80 screening devices is shown in this cross section of a 9-well device in 3 rows  3 columns configuration. The red arrow points to hair
growth on the skin of nude mice in wells containing hMSCs. The black arrow points to the area of the screening device stained with India ink to pinpoint the location of
conditions (rows and columns) after histological processing. Sections of screening devices were stained with haematoxylin and counterstained with eosin showing the
cytoplasm (red) and nuclei (dark blue), where the well is delineated with black lines and the material of the screening device appears to be white and enveloped by the
host tissue (A). The dotted oval in (A) displays the area of interest for screening purposes, where implanted conditions interact with the host tissue. (B) The three wells
are shown after Masson’s tri-chrome staining: keratin (red), collagen (blue) and nuclei (dark brown) to evaluate the extracellular matrix in the wells. Notably, potential
differences in the tissue penetration/formation per well were observed in each well. Scale bar: 1 mm.
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While in vivo cell proliferation was not investigated directly, the
statistics (Tables S1 and S2, ESI†) did not support a significant
correlation between increasing cell numbers and increasing per-
cent areas of tissue (Fig. 4A and B). Since not higher than 50% of
mice displayed a higher percent area of tissue under most condi-
tions, it was concluded that increasing cell numbers were not
sufficient to significantly increase the percent area of tissue in a
well. Other effects such as the reverse trends in percent area of
tissue for chondrocytes (week 2, Fig. 4B) were not significant. The
most significant effect (in 56% of the mice) detected by quantifying
the amount of tissue in a well was found for co-cultures, suggesting
that co-cultures have the potential to induce higher percent areas of
tissue when compared to the readings on empty wells (control),
through ECM formation rather than cell numbers. Thus, it was
concluded that themain contributor to the percent area of tissue in
a well is the well itself probably due to tissue bulging21 or
penetration, which occurs spontaneously when host tissue is in
contact with the well. In order of importance, tissue penetration
was followed by tissue formation as the factor that increases the
amount of tissue in a well as observed in 56% of the mice in wells
with cocultures of four hMSCs to one bPC (80 :20).
Since hMSCs : bPCs cocultures have a known22,23 cartilage
regeneration potential, slides under all conditions were stained
for proteoglycans (Fig. 5). It was found that when compared to
other conditions (Fig. 5B–D), the co-culture containing the
highest amount of hMSCs (80 : 20) was more strongly stained
for proteoglycans (Fig. 5E). Upon histological grading24 (Fig. 5F)
of the quality of neo-cartilage, it was confirmed that all hMSCs :
bPCs combinations produced a cartilage matrix. The 80 : 20
co-culture was the most promising condition tested in this
screening showing in vivo cartilage regeneration as shown by
the significantly higher cartilage (Bern) score on week 4.
To evaluate the results obtained for co-culture ratios using a
conventional method (Fig. S4, ESI†), conditions were seeded in
porous 3D scaffolds16 and implanted subcutaneously in nude
mice. These data also showed that proteoglycans increased in
PEOT–PBT scaffolds containing cocultures with higher quantities
of hMSCs (Fig. S4A, ESI†). The amount of GAG/DNA did not
show a significant difference between groups (Fig. S4B, ESI†).
However, the efficiency of proteoglycans production augmented
with increasing ratios of hMSCs (Fig. S4B, ESI†). Sulphated-
proteoglycans, collagen types I, II and IX confirmed that hyaline
(healthy) cartilage-like tissue was more abundant in scaffolds
with 80% and 90% hMSCs (Fig. S4C, ESI†).
Increasing the number of conditions that could be screened
simultaneously in one animal improves the efficiency and
speed at which therapies and treatments can be identified
and translated into clinical practice. In fact, evaluating the
same 36 in vivo conditions using conventional methods would
have required 9 times the number of mice (Table 2).
Cross talk between wells and their physiological effect is
condition-dependent. While wells in vitro can be independent
of each other by adjusting the well volumes and the relative
humidity, wells in vivo can interact with each other through
soluble factors. The degree of interaction between wells will be
dependent on molecule diffusion dynamics and time. In this
study, ECMmarkers at 2 and 4 weeks did not indicate any cross
talk between wells. However, this will be relative to the marker
of interest. Even though cell therapy in conventional scaffold
systems (50 mm3) occurs in volumes over 25 times larger than
well volumes (1.8 mm3), both systems are consistent with the
regions, where ECM production occurs, which is in the pores in
scaffolds or inside the wells. This indicates that by reducing the
volume of interest in the animal with wells, the extent of desired
and undesired effects such as cross contamination is identifiable
and controllable. As shown here, control can be achieved
through randomization of implanted conditions, which ensures
the discrimination of relevant biological responses, such as
ECM production from irrelevant effects – for the purpose of this
study – such as host tissue penetration in the wells.
Albeit 36 wells were investigated in nude mice as a proof of
principle, the screening device has the potential to become a
high throughput screening (HTS)25,26 system where hundreds
of wells can be contained in one animal with one well (1.8 ml)
for every 1.4 mm of an implantation site. Depending on the size
of the animal, these platforms can be tailored to fit the required
dimensions of an implantation site, which defines the number
Fig. 4 Histological sections (>300 slides) contained tissue penetration/for-
mation in wells which was evaluated through the percent area of tissue, defined
as tissue area/well area  100%. The means (n = 3 slides of a well) of the percent
tissue area for each condition are graphically shown for two representative mice;
one from week 2 and one from week 4. The percent tissue area increased as the
number of cells in a well increased as depicted for hMSCs dilutions and control
(empty well system) (A); bPCs dilutions and control (B).With a total of 25 000 cells
per well in cocultures (C), the percent tissue area increased with higher ratios of
hMSCs to bPCs.
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of conditions that can be implanted (Movie S1, ESI†). Thus, the
larger the animal, the higher the number of conditions that
can be investigated simultaneously. However, the seeding of
macroscopic and large numbers (>100) of wells requires special
equipment to control the microenvironment while dispensing
conditions in all wells with reproducibility. Using the well
system, the number of lives required to perform experiments
in vertebrate animals is inversely proportional to the size of the
Fig. 5 Proteoglycan production was screened as a marker for cartilage formation. Glycosaminoglycans (GAG) (blue) and cytoplasm (red) seen in three wells of
a screening device (A, scale bar: 1 mm). A representative slide of the control and three conditions expressing GAG are displayed: empty wells (B); 25 000 bPCs (C);
co-culture of hMSCs : bPCs at a 20 : 80 ratio (D); co-culture of hMSCs : bPCs at a 80 : 20 ratio (E). Scale bars: 100 mm. Quantification of cartilage quality (F) from
the screened conditions (mean Bern score, N = 10 mice) showed a significantly higher quality of cartilage for hMSCs : bPCs at a 80 : 20 ratio compared to control.
Bern scores were analyzed with Kruskal–Wallis to evaluate significance followed by Bonferroni post hoc correction.
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animal (Table 2), extending the possibility to assess multiple
in vivo conditions. As shown here, standard histological meth-
ods offer an extensive wealth of data, yet methods that avoid
histological processing15,27,28 would be convenient to further
optimize animal experiments, automatize the quantification
and imaging, and improve the sensitivity and throughput of
in vivo screening.
The efficiency of the developed animal-implantable well
system not only lies in optimizing animal experiments, but
also in bridging both in vitro and in vivo milieus. For example,
the well system could be adapted to monitor biomechanics29
and to elucidate gene regulatory networks30,31 in live tissues.
Multiple compounds such as nanoparticles, drugs or chemicals
could be covalently or non-covalently attached to wells to
increase the throughput of toxicity assessments and thereby
drastically dwindle the use of vertebrate animal lives and costs
in pharmaceutical, toxicological, chemical, and disease screen-
ing, while allowing for the first time to execute such screening
in true three-dimensional tissues.
Experimental
Mesenchymal stem cell and chondrocyte isolation and culture
hMSCs and bPCs were isolated, cultured and cryopreserved as
described before.32 hMSCs were obtained from the acetabulum of
five donors who were undergoing total hip replacement surgery
and gave informed consent for bone marrow biopsy, approved by
the medical ethical testing commission (METC) of the Medical
Spectrum Twente in Enschede, The Netherlands. Gender and
donor age were: Donor 1: female, 81 years. Donor 2:male, 65 years.
Donor 3: female, 66 years. Donor 4: female, 66 years. Donors 1 to 3
were cultured in the wells in vitro and only Donor 3 was implanted
in mice. Donor 4 was cultured in the porous scaffolds.
Well system fabrication
A Bioplotter device (Envisiontec GmbH, Germany), which is a
XYZ plotter, was used to make the wells (European Patent
Application: EP2404672A1) with a fabrication process adapted
from that for scaffold fabrication.16 To obtain well systems in a
matrix form (columns  rows) (Fig. S1, ESI†), closed wells were
made by depositing fibers on top of each other at a 901 angle to
obtain rectangular wells, where the first layer deposited was
always closed. The well dimensions were defined by increasing
or decreasing fiber distances in the XY axis and by the height of
the cubical model. This was reproducible with four materials
with their respective parameters as shown in Table S1 (ESI†)
and Fig. 1.
Different architecture designs were fabricated to maximize
the number of wells and to create co-culture systems as shown
in Fig. 1E and F. For the design in Fig. 1E, first and second layer
strand distances were maintained as shown in Table S1 (ESI†)
and a strand distance (0.5 mm) in the middle of the well height
(at 2 mm) was introduced. The design in Fig. 1F did not have a
closed first layer where a constant strand distance (Table S1, ESI†)
was maintained until deposition of a closed layer in the middle of
the well height (at 2 mm). Subsequently, layer deposition with a
constant strand distance was resumed.
In vitro screening
Fluorescent microspheres (YG: l = 441–486 nm) (Polyscience,
Germany), rhodamine (Sigma-Aldrich) and FITC (Sigma-Aldrich)
were diluted in PBS before seeding 1 ml of solution per well of
photopolymerizable resin (Envisiontec, Germany) and poly lactic
acid (Purac, The Netherlands) screening devices. Fluorescence
was imaged in an automatic confocal light microscope (BD
pathway, The Netherlands).
Well sterilization and conditioning for cell culture
Well systems were sterilized with 70% ethanol solution for
15 min, washed three times and incubated at room tempera-
ture for two hours with sterile PBS, and thereafter incubated in
aMEM proliferation media overnight at 37 1C.
Well seeding
From a cell suspension of 5  106 cells per ml, hMSCs were
centrifuged at 200 Relative Centrifugal Force (RCF) and
re-suspended in 0.2 ml of medium. From this cell suspension,
dilutions were prepared with a maximum of 2.5  104 cells in
1 ml volume seeded per well. Every condition (i.e. cell dilutions)
was seeded in all the wells of a column. In a 3  3 well system,
three replicates or three wells were seeded under the same
condition. Seeded wells were incubated for 20 min at 37 1C in a
humid atmosphere with 5% CO2. Non-detached cells in a well
were removed by washing with culture medium, then these
were placed in a well of a 25-well plate (Nunc), and covered with
the culture medium of hMSCs or bPCs and incubated at 37 1C.
In vitro cell culture
Cell numbers in wells were obtained using Cyquant DNA assay
(Invitrogen). Cell numbers were calibrated for hMSCs by
measuring the mg of DNA per cell of cell numbers from 1  103
to 3  105 cells against known DNA amounts. It was estimated
that each hMSC contained 1.6 picograms of DNA, which made it
possible to quantify cell numbers in wells.
Table 2 Projection of animals saved with implantable wells vs. a conventional method in a similar experimental set-up
Species
Experimental
conditions
# Animals with conventional
methods (n = 10 animals)
3D HTS
well matrix
Size
[mm]
Conditions
per 3D HTS
Wells per
animal
# Animals with
3D HTS
Animals
saved
Mouse 36 90 3  3 4.2 9 36 10 80
Rats 576 1440 12  12 16.8 144 576 10 1430
Rabbits 1600 4000 20  20 28 400 1600 10 3990
Goats 4096 10 240 32  32 44.8 1024 4096 10 10 230
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Co-culture preparation in wells
Human MSCs : bPCs were seeded in wells in aMEM prolifera-
tion media. Each of the three ratios (0.8 : 0.2, 0.5 : 0.5, and
0.2 : 0.8) was seeded in three wells of a 3  3 well system, which
contained a maximum of 2.5  104 cells per well.
Implantations in immune-deficient mice
Nude mice studies were performed after consent from
the ethical committee for animal studies (DEC-GDL Utrecht,
The Netherlands). Six-week-old nude mice (Hdcpb :NMRI-nu
Harlan, The Netherlands) were anaesthetized with 0.02 ml of a
3.5 : 3 : 1 mixture of ketamine (100 mg ml1) : xylazine (20 mg ml1) :
atropine (0.5 mg ml1).
Four 3  3 well systems containing 36 conditions were
subcutaneously implanted per mouse in the posterior-lateral
side of the back and sutured. The 36 conditions implanted were
triplicates of: three dilutions of hMSCs (25 000; 12 000; and
6000 cells); three dilutions of bPCs (25 000; 12 000; and 6000
cells); three hMSCs : bPCs ratios (0.8 : 0.2, 0.5 : 0.5, and 0.2 : 0.8)
and empty wells with no cells. Conditions were randomized by
dispensing them in different wells of screening devices and
implanting devices in different pockets from one mouse to another
(Fig. S3A, ESI†). After 2 weeks (n = 10) and 4 weeks (n = 10) mice
were euthanized via CO2 asphyxiation and screening systems were
excised and processed for analysis.
Histology of screening devices
3  3 well systems were explanted, washed in PBS and fixed in
10% formalin at 4 1C overnight. After washing in PBS, wells
were embedded in paraffin and cut into 5 mm sections using a
microtome. Slides containing sections of 80 well systems were
stained with haematoxylin and counterstained with eosin
(H&E); alcian blue and counterstained with nuclear red; and
Masson’s tri-chrome. These samples were examined by GAH,
LW, LMT and JL under direct supervision of CvB, LM and MK
with a proven track record in histological evaluation of
implants of more than 20 years.
Tissue quantification in wells
Slides showing 3  3 well system’s rows were stained with
H&E, Masson’s trichrome and alcian blue and imaged using
light microscopy. Image analysis was performed for the area
containing each condition on B350 representative slides,
obtained from 80 screening devices and 3 representative
sections per well. Images were processed by cutting the images
of wells (Fig. S3B, ESI†) and converting them to a binary pixel
image (Fig. S3C, ESI†) using ImageJ software (open source).
Black and white pixels within an image of a well were quanti-
fied with the histogram function in ImageJ, where the mean
(n = 3 slides) of the percent area of tissue was obtained for each
explanted well system. Using a binary system, where black
represented tissue and white represented lack of tissue in a well,
it was possible to avoid thresholding biases and to quantify the
pixels in the wells. In this manner, nuclei, cytoplasm and ECM
(keratin, collagen and GAG) appeared as black pixels, and every-
thing else as white pixels.
Bern score of cartilage in wells
The visual histological grading or the Bern score for the
evaluation of neocartilage was performed by three independent
observers as previously shown24 for representative slides of
conditions showing cartilage formation with alcian blue and
counterstained with nuclear fast red. 170 images were printed,
randomly organized and separately assessed by each independent
observer to obtain a score for each condition in 20 mice.
Two-dimensional PEOT–PBT discs
Poly(ethylene oxide terephthalate)–poly(butylene terephthalate)
(PEOT–PBT) was used to make 2D substrates, following an
aPEOTbPBTc nomenclature, a is the molecular weight in
g mol1 of the starting PEG block for copolymerization, whereas
b and c are the respective weight fractions of the PEOT and PBT
blocks. Specifically, 300PEOT55PBT45 was used to manufacture
2D substrates by a hot-embossed compression molding tech-
nique, where two silicon wafers served as a support and defined
the molded surface. A stainless steel mold with circular features
through holes of 2.2 cm in diameter was placed in between the
molds. Granules of 300PEOT55PBT45 were placed inside
the mold to fill up the mold cavities upon polymer melting.
Silicon supports were cleaned by immersion in piranha solution
(3 : 1 concentrated H2SO4–33% aqueous H2O2) for 15 min. These
were rinsed with water and dried in N2. Then, they were function-
alized with 1H,1H,2H,2H-perfluorodecyltrichlorosilane (ABCR).
After that, these were deposited in the gas phase that served as
an anti-adhesion layer to ease the polymer–support separation.
For the hot embossing process, a hydraulic press equipped with a
water cooling system and temperature control (Fortune, Holland,
The Netherlands) was used. The 300PEOT55PBT45 was placed on
top of the silicon support and in the aperture of the mold. Then,
the system was heated up to a temperature of 180 1C and 10 bars
were applied. After 5 minutes the system cooled down to 60 1C
and the pressure was released. The mold and the supports were
manually separated and the 2D disc released from the mold.
3D scaffold fabrication
The bioplotter device was also used to manufacture porous
scaffolds. According to a previous study,16 co-polymers were
molten and deposited as successively layered fibers in a 0–90
pattern from a 250 mm nozzle onto a computer aided x/y/z table
with a layer thickness of 0.15 mm and a fiber spacing of
0.6 mm. Cylindrical scaffolds (+4  4 mm) with constant pore
size and 100% interconnecting pore volume were cored and
sterilized in isopropyl alcohol.
Seeding and co-culture of bovine PCs and human MSCs in
scaffolds
Cylindrical scaffolds were extensively rinsed in phosphate
buffered saline (PBS), incubated overnight in proliferation
medium and blotted dry prior to seeding. Bovine primary
chondrocytes were mixed with hMSCs, respectively, at a
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total of 3 million cells per scaffold, centrifuged at 300g for
5 minutes and re-suspended in 54 ml of medium containing
300 mg ml1 fibronectin. Scaffolds were seeded statically with
3  106 cells per scaffold for 1 day before subcutaneous
implantation in nude mice.
Implantation of bovine PCs and human MSCs in scaffolds
With 4 implants maximum per mouse, nine constructs of
bovine PCs : hMSCs (n = 9) per experimental group (7 groups =
4 co-cultures plus 3 controls) were randomly implanted in 16
nude mice.
Histology and immunohistochemistry with scaffolds
Three constructs per donor were explanted, washed in PBS,
fixated in formalin at 4 1C overnight. After washing in
PBS, constructs were cut into 2 halves, one half was embedded
in GMA and one half was embedded in Tissue-Tek for
immunohistochemistry. GMA embedded 3D scaffolds were
cut into 5 mm sections which were treated with safranin-O
(red) to stain sulphated-proteoglycans, hematoxylin (dark blue)
to mark the nuclei and with fast green (light blue) to label the
cytoplasm. Scaffolds (n = 3) were embedded and immediately
frozen at 80 1C in OCT compound (Tissue-Tek) for immuno-
staining. Sections were cut using a cryo-microtome to a thick-
ness of 5 mm and fixated with acetone for 10 minutes, stained
for collagen type-I (1 : 1000, Ab-1, Calbiochem), type-II (1 : 100,
DSHB II-II6B3), and type-IX (1 : 100, DSHB D1-9). Blocking was
achieved with 10% human serum and secondary antibody was
goat anti-mouse (1 : 100, DAKO). Staining was visualized through
incubation of slides in 3,3-diaminobenzidine (DAB)–solution
(DAKO) for 10–20 minutes. These samples were examined by
JH, MvdD and RS under direct supervision of CvB, LM and MK.
Statistical analysis
Normality of the data was analyzed by determining skewness
being between 3 and 3 and showed normal distribution of the
data in all groups. In vitro fluorescent data were analyzed for
each condition as the mean (n = 12 wells) emission of wells with
one-way Anova followed by Tukey’s honestly significant differ-
ence criterion with statistical significance set at p o 0.01.
Quantitative GAG and DNA data from scaffolds were analyzed
for differences of the means (n = 5 scaffolds) with two-way
Anova followed by Tukey’s honestly significant difference cri-
terion, where statistical significance was set at p o 0.01.
In vivo screening of conditions was organized in replicates
with a multi-dimensional sample number, which was defined by
N = 10 animals and n = 3 replicates per well for each condition in
each animal. So that n = 3 replicates per condition per mouse
and the total sample number per condition is N  n = 30.
The mean (n0 = 3 histological slides) of the percent area of
tissue was analyzed for each screening device in each statisti-
cally independent mouse (n = 3 wells per condition in each
animal) with one-way Anova followed by Tukey’s honestly
significant difference criterion where statistical significance was
set at p o 0.05. So that for each mouse, there were n0  n = 9
images of the same condition available for analysis.
Since Bern score data are non-parametric, it was not
normally distributed data. To account for that, Bern scores of
differences of means (N = 10 mice) for glycosaminoglycans
in the well system were analyzed with Kruskal–Wallis with
Bonferroni post hoc correction. Three independent observers
assessed the Bern scores for each slide, where inter-observer
reproducibility was evaluated with the hypothesis of a combined
effect on Bern scores by both mean observers’ score for a slide
and a mean score for a condition causing a statistical significant
difference set at p o 0.05.
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